Preclinical Safety Assessment of LNP-Formulated Drugs & Vaccines
Time: 3:30 pm
day: Conference Day One
Details:
- Determining the most effective control to measure base immunogenicity of LNP
- Reviewing how different cargos might interact with nanoparticle characteristics and subsequently alter safety profile
- Testing immunogenicity with and without cargo to determine if cargo or payload impacts LNP safety
